Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
News|Videos|October 14, 2026
What ACOG's 2026-27 respiratory virus guidance means in practice
Fact checked by: Joshua Fitch, Senior Editor
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
Advertisement
Advertisement
Welcome to this Contemporary OB/GYN Special Report series on maternal immunization heading into the 2026-27 respiratory season. Across 5 episodes, our host and experts examine what the latest guidance means in practice for obstetric and pediatric clinicians and for the patients they counsel.
Related to this article
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
Advertisement
Advertisement